The molecular / cytogenetic classification in
multiple myeloma helps identify patients into poor,
intermediate, & good risk categories. FISH, using
a disease specific set of probes, detects abnormalities
seen in the majority of multiple myeloma cases.
Chromosomal analysis is also predictive. Patients
with a 13q14 and 17p13 deletions have shortened
survival.
TEST SCHEDULES
TESTS 
